MeCP2 mutations: progress towards understanding and treating Rett syndrome

被引：54
|
作者：
Shah, Ruth R. [1 ]
Bird, Adrian P. [1 ]
机构：
[1] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Max Born Crescent, Edinburgh EH16 5DS, Midlothian, Scotland
来源：
GENOME MEDICINE | 2017年 / 9卷
基金：
英国惠康基金;
关键词：
SEVERITY;
D O I：
10.1186/s13073-017-0411-7
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Rett syndrome is a profound neurological disorder caused by mutations in the MECP2 gene, but preclinical research has indicated that it is potentially treatable. Progress towards this goal depends on the development of increasingly relevant model systems and on our improving knowledge of MeCP2 function in the brain.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2
    Sajan, Samin A.
    Jhangiani, Shalini N.
    Muzny, Donna M.
    Gibbs, Richard A.
    Lupski, James R.
    Glaze, Daniel G.
    Kaufmann, Walter E.
    Skinner, Steven A.
    Annese, Fran
    Friez, Michael J.
    Lane, Jane
    Percy, Alan K.
    Neul, Jeffrey L.
    GENETICS IN MEDICINE, 2017, 19 (01) : 13 - 19
  • [42] Bone Mass in Rett Syndrome: Association With Clinical Parameters and MECP2 Mutations
    Shapiro, Jay R.
    Bibat, Genila
    Hiremath, Girish
    Blue, Mary E.
    Hundalani, Shilpa
    Yablonski, Theodore
    Kantipuly, Aditi
    Rohde, Charles
    Johnston, Michael
    Naidu, Sakkubai
    PEDIATRIC RESEARCH, 2010, 68 (05) : 446 - 451
  • [43] Rett syndrome with and without detected MECP2 mutations: An attempt to redefine phenotypes
    Temudo, Teresa
    Santos, Monica
    Ramos, Elisabete
    Dias, Karin
    Vieira, Jose Pedro
    Moreira, Ana
    Calado, Eulalia
    Carrilho, Ines
    Oliveira, Guiomar
    Levy, Antonio
    Barbot, Clara
    Fonseca, Maria
    Cabral, Alexandra
    Cabral, Pedro
    Monteiro, Jose
    Borges, Luis
    Gomes, Roseli
    Mira, Graca
    Pereira, Susana Aires
    Santos, Manuela
    Fernandes, Anabela
    Epplen, Jorg T.
    Sequeiros, Jorge
    Maciel, Patricia
    BRAIN & DEVELOPMENT, 2011, 33 (01): : 69 - 76
  • [44] MECP2 mutations account for most cases of typical forms of Rett syndrome
    Bienvenu, T
    Carrié, A
    de Roux, N
    Vinet, MC
    Jonveaux, P
    Couvert, P
    Villard, L
    Arzimanoglou, A
    Beldjord, C
    Fontes, M
    Tardieu, M
    Chelly, J
    HUMAN MOLECULAR GENETICS, 2000, 9 (09) : 1377 - 1384
  • [45] Mice with human mutations of the MeCP2 gene as animal models of Rett syndrome
    Coyle, JT
    Tsai, GC
    Jiang, I
    Tai, TC
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S139 - S139
  • [46] Rett mutations attenuate phase separation of MeCP2
    Fan, Chunyan
    Zhang, Honglian
    Fu, Liangzheng
    Li, Yuejiao
    Du, Yi
    Qiu, Zilong
    Lu, Falong
    CELL DISCOVERY, 2020, 6 (01)
  • [47] Rett mutations attenuate phase separation of MeCP2
    Chunyan Fan
    Honglian Zhang
    Liangzheng Fu
    Yuejiao Li
    Yi Du
    Zilong Qiu
    Falong Lu
    Cell Discovery, 6
  • [48] Spectrum of MECP2 mutations in Iranian Azeri Turkish Rett syndrome patients
    Nazm, Saba Ahmadpour
    Jahanafrooz, Zohreh
    Bonyadi, Mortaza
    Masoudi, Noushin
    Nouri, Zahra
    Barzegar, Mohammad
    NEUROLOGY ASIA, 2023, 28 (02) : 381 - 385
  • [49] Bone mass in rett syndrome: Association with clinical parameters and MECP2 mutations
    Shapiro J.R.
    Bibat G.
    Hiremath G.
    Blue M.E.
    Hundalani S.
    Yablonski T.
    Kantipuly A.
    Rohde C.
    Johnston M.
    Naidu S.
    Pediatric Research, 2010, 68 (5) : 446 - 451
  • [50] Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies
    Sandweiss, Alexander J.
    Brandt, Vicky L.
    Zoghbi, Huda Y.
    LANCET NEUROLOGY, 2020, 19 (08): : 689 - 698
12345